Siga Technologies gets orders worth $28 mln for antiviral drug
July 12 (Reuters) - Drugmaker SIGA Technologies SIGA.O said on Tuesday it has received orders worth about $28 million for its oral antiviral drug Tpoxx, as monkeypox cases spread globally. (Reporting by Mrinalika Roy in Bengaluru; Editing by Devika Syamnath) ((mrinalika.roy@thomsonreuters.com;))
Recent news on SIGA Technologies
See all newsBrief: Siga Secures Contract Valued At Up To $15 Million From Canadian Department Of National Defence To Purchase Tpoxx®
SIGA Technologies Q2 revenue, profit drop as contract ends
SIGA Technologies Q1 revenue falls, net loss widens
Brief: SIGA Technologies Q1 EPS USD -0.05
Brief: EMA Recommends Restricting Use Of Tecovirimat SIGA